•  
  •  
  •  
  •  

2025-10-01 14:01:31

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Escorts Kubota Ltd Tractor Volume grew by 47.6% in September 2025
  • VinFast India signs MoU with Castrol India to strengthen EV after-sales service network
  • Shriram AMC Strengthens Fixed Income Expertise with appointment of Amit Modani as Senior Fund Manager
  • RMC Switchgears Ltd receives LOAs amounting to Rs. 100.19 crores
  • Hi-Tech Pipes Ltd achieves highest ever sales volume for Q2 and H1 during FY2025-26

Keywords Selected:  Nagpur

Stock Report

  • Lupin receives 6 observations from USFDA for Nagpur Injectable facility
  • TEMBO Defence Receives Comfort Letter from MIDC for 100 Acres Arms and Ammunition Manufacturing Facility in Amravati, Maharashtra
  • HomeTown Broadens Its Horizons with New Store Openings Across India!
  • Avenue Supermarts Limited opens new store at Nagpur
  • Route Mobile Limited enables WhatsApp-based ticketing for Nagpur, Pune, Hyderabad and Delhi Metro
  • Lupin announces closure of US FDA Inspection at its Injectable Facility with Zero 483 Observations
  • IndiGo announces new flights connecting North Goa, Nagpur, and Chhatrapati Sambhajinagar
  • Airtel strengthens its retail footprint in Nagpur
  • Infosys inaugurates new Development Center in Nagpur
  • Lupin Receives EIR from U.S. FDA for its Nagpur Unit-1 Manufacturing Facility
  • Godrej Properties acquires ~109 acres land parcel in Nagpur
  • Sundaram Multi Pap Ltd to monetize its non-core asset, an industrial land in Sihora, Nagpur
  • Alphalogic Industries Ltd wins order from Haldirams
  • Lupin's Nagpur Oral Solid Dosage facility gets 2 observations from USFDA
  • IndusInd Bank inaugurates new branch in Nagpur, its 15th in the city
  • G G Dandekar Machine Works Ltd to close down operations at Butibori Plant
  • Lupin Receives EIR from US FDA for its Injectable Facility in Nagpur
  • Lupin receives approval from US FDA for Glycopyrrolate Injection, USP
  • Infosys Foundation Diabetes Care Program to help in remission of Type 2 Diabetes
  • Airtel powers Dr. Babasaheb Ambedkar International Airport with ultrafast Airtel 5G Plus
  • US FDA Inspection of Lupin's Nagpur Unit-2 injectable manufacturing facility
  • Airtel 5G Plus launched today
  • KIMS HOSPITALS to acquire majority stake in Kingsway Hospitals, Nagpur
  • Cineline India approves issue of 27 lakh warrants at Rs. 130 per warrant

Latest Post

  • Escorts Kubota Ltd Tractor Volume grew by 47.6% in September 2025
  • VinFast India signs MoU with Castrol India to strengthen EV after-sales service network
  • Shriram AMC Strengthens Fixed Income Expertise with appointment of Amit Modani as Senior Fund Manager
  • RMC Switchgears Ltd receives LOAs amounting to Rs. 100.19 crores
  • Hi-Tech Pipes Ltd achieves highest ever sales volume for Q2 and H1 during FY2025-26


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024